宜通世纪科技股份有限公司 简式权益变动报告书 上市公司名称：宜通世纪科技股份有限公司 股票上市地点：深圳证券交易所 股票简称：宜通世纪 股票代码：300310 信息披露义务人：史亚洲 通讯地址：广州市华南碧桂园**** 权益变动性质：不涉及持股数量增减，一致行动协议终止解除一致行动关系 签署日期：2025 年 11 月 11 日 信息披露义务人声明 一、信息披露义务人是根据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司收购管理办法》（以 下简称《收购办法》）、《公开发行证券的公司信息披露内容与格式准则第 15 号— 权益变动报告书》及其他相关法律、法规及部门规章的有关规定编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准。 三、依据《证券法》、《上市公司收购管理办法》的规定，本报告书已全面披 露信息披露义务人在宜通世纪科技股份有限公司（以下简称"公司"或"宜通世纪"） 中拥有权益的股份变动情况；截至本报告书签署之日，除本报告书披露的信息外， 上述信息披露义务人没有通过任何其他方式增加或减少其在宜通世纪中拥有权 益的股份。 四、本次 ...

证券代码：300310 证券简称：宜通世纪 公告编号：2025-044 二、本次变更后的签字注册会计师的基本情况 俞健业，2014 年取得注册会计师资格，自 2010 年起从事上市公司审计，2022 年开始在司农会计师事务所执业，现任司农会计师事务所合伙人。 刘超，2023 年取得注册会计师资格，自 2019 年起从事上市公司审计，2023 年开始在司农会计师事务所执业，现任司农会计师事务所项目经理。 俞健业和刘超不存在违反《中国注册会计师职业道德守则》有关独立性要 求的情形，最近三年未曾因执业行为受到过刑事处罚、行政处罚、监督管理措 施和纪律处分。 宜通世纪科技股份有限公司 关于变更签字注册会计师的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 宜通世纪科技股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日召开 第五届董事会第十三次会议、第五届监事会第十一次会议，2025 年 9 月 1 日召 开2025年第一次临时股东大会，审议通过了《关于拟续聘会计师事务所的议案》， 公司续聘广东司农会计师事务所（特殊普通合伙）（以下简称"司农会计师 ...

证券代码：300310 证券简称：宜通世纪 公告编号:2025-043 宜通世纪科技股份有限公司（以下简称"公司"或"宜通世纪"）于 2025 年 11 月 3 日收到广东省高级人民法院出具的《民事裁定书》（2023）粤民终 5131 号。 根据《深圳证券交易所创业板股票上市规则》关于信息披露的相关规定，现将涉 及的诉讼进展事项公告如下： 一、诉讼事项的基本情况 因深圳市倍泰健康测量分析技术有限公司（以下简称"倍泰健康"）原法定代 表人、实际控制人方炎林在宜通世纪并购倍泰健康过程中对公司实施合同诈骗， 为维护公司和全体股东的合法权益，公司依法向广州市中级人民法院提起诉讼， 请求法院撤销公司在并购倍泰健康时与交易对方签署的资产购买协议及补充协 议，判令各交易对方返还其因该购买协议所获得的财产给公司，并且赔偿公司因 此所受到的损失。 2022 年 6 月 24 日，广州市中级人民法院受理了公司的起诉，详见公司于 2022 年 6 月 24 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于公司涉及诉讼的 公告》（公告编号：2022-021）。 宜通世纪科技股份有限公司 关于涉及诉讼事项的进展公告 本 ...

Core Viewpoint - The company clarified that it has no business cooperation with Tesla and that its previous agency agreement related to IoT platforms will not be renewed after December 31, 2024, indicating a shift in focus away from this area [1] Group 1 - The company confirmed there is no collaboration with Tesla [1] - The previous agency agreement for IoT platforms will expire on December 31, 2024, and will not be renewed [1] - The company noted that FSD (Full Self-Driving) and IoT are deeply synergistic and complementary, suggesting that investor expectations for FSD may influence perceptions of IoT [1]

Core Viewpoint - The company, Yitong Century, clarified that it has no business cooperation with Tesla, despite previous involvement in related IoT platforms which will not be renewed after December 31, 2024 [1] Group 1: Company Relationship with Tesla - The company confirmed that there is no current business collaboration with Tesla [1] - Previous agency work related to IoT platforms is set to expire at the end of 2024, and the company will not renew the contract [1] Group 2: Market Perception - The company noted that the high expectations investors have for Tesla's Full Self-Driving (FSD) technology may influence perceptions of the IoT sector [1]

Core Viewpoint - The company, Yitong Century, emphasizes its commitment to telecommunications services while exploring opportunities in other fields such as IoT and big data to drive future growth [1] Group 1 - The company's strategy focuses on strengthening its traditional telecommunications business [1] - The company is actively monitoring and exploring other sectors to identify new growth opportunities [1] - The transition from telecommunications services to information services like IoT and big data is seen as a potential avenue for future performance improvement [1]

Core Viewpoint - The company confirmed that its production and operations are normal as of October 30, 2025, and referenced its third-quarter report for detailed financial data [2] Group 1 - The company responded to investor inquiries on an interactive platform [2] - The company disclosed its third-quarter report for 2025 on October 28, 2025 [2] - Investors are encouraged to refer to the company's relevant reports for specific operational data for the first three quarters of 2025 [2]

Core Viewpoint - Yitong Century Technology Co., Ltd. has disclosed its third-quarter report for 2025, ensuring the accuracy and completeness of the information provided [1] Group 1 - The third-quarter report was published on October 28, 2025, on the designated information disclosure website of the China Securities Regulatory Commission [1] - The company and its board members guarantee that the disclosed information is true, accurate, and complete, with no false records or misleading statements [1]

Core Viewpoint - The article discusses the ongoing legal issues faced by Yitong Century (宜通世纪) due to false statements leading to investor claims, with a significant number of lawsuits currently in progress [1][3]. Group 1: Legal Proceedings - As of June 30, 2025, Yitong Century has received civil lawsuits from 356 investors, totaling approximately RMB 27.27 million due to securities false statement disputes [1]. - Out of the lawsuits, 191 cases have been concluded, with a total compensation of about RMB 11.76 million paid [1]. - Two cases have received a first-instance judgment involving an amount of RMB 37,181.07, and are currently in the second-instance process [1]. Group 2: Financial Misconduct - From May 1 to December 31, 2017, Yitong Century's subsidiary, Beitai Health, inflated revenue by RMB 97.34 million, costs by RMB 52.61 million, and total profit by RMB 40.84 million, which represented 3.7%, 9.75%, and 15.67% of the reported figures, respectively [2]. Group 3: Investor Compensation - Investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and sold or continued to hold their shares after November 4, 2022, are still eligible to file for compensation without incurring any costs [3].

Group 1 - The core point of the article is that Yitong Century (300310.SZ) reported a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Group 2 - The company's operating revenue for the first three quarters was 1.694 billion yuan, representing a year-on-year decrease of 5.04% [1] - The net profit attributable to shareholders of the listed company was 3.3925 million yuan, showing a significant year-on-year decrease of 86.05% [1] - The net loss attributable to shareholders, after deducting non-recurring gains and losses, was 5.084 million yuan [1] - The basic earnings per share were 0.0038 yuan [1]